Rojas-Montaño A

Idioma: Español
Referencias bibliográficas: 16
Paginas: 82-85
Archivo PDF: 172.13 Kb.

FRAGMENTO

En todos los pacientes candidatos a trasplante renal (TR) consideramos como obligatorio se realice una evaluación de la función pulmonar, cuyo objetivo primordial será la búsqueda de factores de riesgo para complicaciones pulmonares postquirúrgicas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998; 113: 883-889.

2. Wellman JJ, Smith BA. Respiratory complications of surgery. In: Lubin MF, Walker HK, Smith RB, editors. Medical management of the surgical patient. Boston: Butterworth; 1988. pp. 155-60.

3. Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol. 2000; 11: 753.

4. Johnson DW, Isbel NM, Brown AM, Kay TD, Franzen K, Hawley CM et al. The effect of obesity on renal transplant outcomes. Transplantation. 2002; 74: 675-681.

5. Schwarznau A, Matevossian E, Novotny A, Stangl M. Outcome of living donor renal transplantation in obese recipients. Transplant Proc. 2008; 40: 921-922.

6. Issa N, Krowka MJ, Griffin MD et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008; 86 (10): 1384-1388.

7. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019; 53 (1). pii: 1801904.

8. Jaber S, Delay JM, Chanques G, Sebbane M, Jacquet E, Souche B et al. Outcomes of patients with acute respiratory failure after abdominal surgery treated with noninvasive positive pressure ventilation. Chest. 2005; 128: 2688-2695.

9. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005; 45: 1691-1699.

10. Hansen EF, Phanareth K, Laursen LC et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159 (4 pt 1): 1267-1271.

11. Chailleux E, Fauroux B, Binet F et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR observatory. Chest. 1996; 109 (3): 741-794.

12. Mjoen G, Oyen O, Holdaas H et al. Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry. Transplantation. 2009; 88: 1273-1279.

13. Axelrod D, Lentine KL, Schnitzler MA, Luo X, Xiao H, Orandi BJ et al. The incremental cost of incompatible living donor kidney transplantation: a national cohort analysis. Am J Transplant. 2017; 17 (12): 3123-3130.

14. Abecassis M, Adams M, Adams P et al. Consensus statement on the live organ donor. JAMA. 2000; 284: 2919-2926.

15. Qaseem A, Snow V, Fitterman N et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing non cardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006; 144: 575-580.

16. Clavien PA, Barkun J, de Oliveira ML et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250: 187-196.